| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11745-010-3401-8 |
| P698 | PubMed publication ID | 20224977 |
| P2093 | author name string | Alireza Esteghamati | |
| Omid Khalilzadeh | |||
| Afsaneh Morteza | |||
| Leila Khajeali | |||
| Manouchehr Nakhjavani | |||
| Arsia Jamali | |||
| Sheida Dadkhahipour | |||
| P2860 | cites work | Circulating oxidized LDL is associated with parameters of the metabolic syndrome in postmenopausal women. | Q51498588 |
| Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia | Q58421218 | ||
| Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability | Q72546747 | ||
| Effects of advanced glycation endproducts on the generation of macrophage-mediated oxidized low-density lipoprotein | Q73870549 | ||
| Statin therapy depresses total body fat oxidation in the absence of genetic limitations to fat oxidation | Q80102050 | ||
| Diagnosis and classification of diabetes mellitus | Q80423340 | ||
| Novel therapeutic strategies targeting vascular redox in human atherosclerosis | Q84056005 | ||
| Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 | ||
| Oxidized LDL and small LDL particle size are independently predictive of a selective defect in microcirculatory endothelial function in type 2 diabetes | Q28185611 | ||
| The pathobiology of diabetic complications: a unifying mechanism | Q29617766 | ||
| Inflammation, atherosclerosis, and arterial thrombosis: role of the scavenger receptor CD36 | Q33606906 | ||
| Lipoprotein oxidation and atherosclerosis. | Q34253107 | ||
| Pathophysiology of oxidative stress in diabetes mellitus | Q34310277 | ||
| Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the Health, Aging and Body Composition Study | Q35717014 | ||
| Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities | Q35791924 | ||
| Oxidative stress and antioxidant treatment in diabetes | Q36064410 | ||
| Clinical significance of the physicochemical properties of LDL in type 2 diabetes | Q36097806 | ||
| Hyperglycemia, lipoprotein glycation, and vascular disease | Q36218217 | ||
| A review on the role of antioxidants in the management of diabetes and its complications | Q36218881 | ||
| Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome | Q36925959 | ||
| Diabetic vasculopathy and the lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1). | Q37065778 | ||
| Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease. | Q37231252 | ||
| The oxidation ratio of LDL: a predictor for coronary artery disease | Q37363246 | ||
| Oxidative stress, diabetes, and diabetic complications | Q37613032 | ||
| Oxidized low-density lipoprotein and intimal medial thickness in subjects with glucose intolerance: the Chennai Urban Rural Epidemiology Study-25. | Q39782131 | ||
| Relationship between level of circulating modified LDL and the extent of coronary artery disease in type 2 diabetic patients | Q40168191 | ||
| Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population | Q40402572 | ||
| Low density lipoprotein oxidation and its pathobiological significance | Q41566828 | ||
| Association between oxidant/antioxidant markers and proteinuria in type 2 diabetes: results in 142 patients | Q43228259 | ||
| Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study). | Q44063974 | ||
| Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes | Q44795860 | ||
| The effect of statins and fibrates on interferon-gamma and interleukin-2 release in patients with primary type II dyslipidemia | Q45068326 | ||
| Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis | Q45226403 | ||
| Autoantibodies against oxidized LDLs and atherosclerosis in type 2 diabetes | Q45285728 | ||
| Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia | Q46076543 | ||
| Association of oxidized low-density lipoprotein and transforming growth factor-beta in type 2 diabetic patients: a cross-sectional study | Q46166372 | ||
| Effect of cranberry extracts on lipid profiles in subjects with Type 2 diabetes | Q46221172 | ||
| The protective effect of fluvastatin on hydroxyl radical generation by inhibiting low-density lipoprotein (LDL) oxidation in the rat myocardium | Q46327474 | ||
| Circulating oxidized LDL: determinants and association with brachial flow-mediated dilation | Q46359070 | ||
| Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases | Q46467576 | ||
| Advanced glycation end products serve as ligands for lectin-like oxidized low-density lipoprotein receptor-1(LOX-1): biochemical and binding characterizations assay | Q46476726 | ||
| Proportion of oxidized LDL relative to plasma apolipoprotein B does not change during statin therapy in patients with heterozygous familial hypercholesterolemia | Q46591628 | ||
| Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients | Q46974944 | ||
| Association of macroalbuminuria with oxidized LDL and TGF-beta in type 2 diabetic patients: a case-control study. | Q51416358 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 321-327 | |
| P577 | publication date | 2010-03-12 | |
| P1433 | published in | Lipids | Q15756668 |
| P1476 | title | Serum oxidized-LDL is associated with diabetes duration independent of maintaining optimized levels of LDL-cholesterol | |
| P478 | volume | 45 |
| Q51609733 | Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome. |
| Q84143689 | Amelioration of lipid abnormalities by α-lipoic acid through antioxidative and anti-inflammatory effects |
| Q42622287 | Anti-oxLDL antibodies are clinically insignificant for stroke patients |
| Q55081788 | Association between circulating oxidized low-density lipoprotein and atherosclerotic cardiovascular disease. |
| Q47671871 | Causal effects of cardiovascular risk factors on onset of major age-related diseases: A time-to-event Mendelian randomization study |
| Q37660758 | Correlation of Body Mass Index and Serum Parameters With Ultrasonographic Grade of Fatty Change in Non-alcoholic Fatty Liver Disease |
| Q60956493 | DUSP1 Is a Potential Marker of Chronic Inflammation in Arabs with Cardiovascular Diseases |
| Q36487547 | Determinants and clinical significance of plasma oxidized LDLs in older individuals. A 9 years follow-up study |
| Q37431527 | Diabetes and increased lipid peroxidation are associated with systemic inflammation even in well-controlled patients. |
| Q28554206 | Endoplasmic Reticulum Stress Links Oxidative Stress to Impaired Pancreatic Beta-Cell Function Caused by Human Oxidized LDL |
| Q35883396 | Increased LDL susceptibility to oxidation accelerates future carotid artery atherosclerosis |
| Q36172775 | Increased serum oxidized low-density lipoprotein levels in pregnancies complicated by gestational diabetes mellitus |
| Q36340275 | Lentil Sprouts Effect On Serum Lipids of Overweight and Obese Patients with Type 2 Diabetes |
| Q64053831 | Measurement and Clinical Significance of Lipid Peroxidation as a Biomarker of Oxidative Stress: Oxidative Stress in Diabetes, Atherosclerosis, and Chronic Inflammation |
| Q91844371 | Middle-Aged Indians with Type 2 Diabetes Are at Higher Risk of Biological Ageing with Special Reference to Serum CDKN2A |
| Q36123765 | Oxidative Stress, DNA Damage and DNA Repair in Female Patients with Diabetes Mellitus Type 2 |
| Q42240864 | Oxidized Low Density Lipoprotein and High Sensitive C-Reactive Protein in Non-Diabetic, Pre-Diabetic and Diabetic Patients in the Acute Phase of the First Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention |
| Q51389877 | Oxidized Low-Density Lipoprotein Is Negatively Correlated With Lecithin-Cholesterol Acyltransferase Activity in Type 2 Diabetes Mellitus |
| Q38299279 | Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases |
| Q35899089 | Pulsatile Hyperglycaemia Induces Vascular Oxidative Stress and GLUT 1 Expression More Potently than Sustained Hyperglycaemia in Rats on High Fat Diet |
| Q39588885 | Receptor mediated elevation in FABP4 levels by advanced glycation end products induces cholesterol and triacylglycerol accumulation in THP-1 macrophages |
| Q27317203 | Reduction of connexin36 content by ICER-1 contributes to insulin-secreting cells apoptosis induced by oxidized LDL particles |
| Q35145993 | Role for inducible cAMP early repressor in promoting pancreatic beta cell dysfunction evoked by oxidative stress in human and rat islets |
| Q38184614 | Role of Toll-like receptors in diabetic nephropathy |
| Q26995308 | Role of microRNAs in islet beta-cell compensation and failure during diabetes |
| Q51350390 | Serum parameters predict the severity of ultrasonographic findings in non-alcoholic fatty liver disease. |
| Q33749982 | Statin therapy reduces oxidized low density lipoprotein level, a risk factor for stroke outcome |
| Q91641006 | The Beneficial Effects of Alpha Lipoic Acid Supplementation on Lp-PLA2 Mass and Its Distribution between HDL and apoB-Containing Lipoproteins in Type 2 Diabetic Patients: A Randomized, Double-Blind, Placebo-Controlled Trial |
| Q39883075 | The common variant Q192R at the paraoxonase 1 (PON1) gene and its activity are responsible for a portion of the altered antioxidant status in type 2 diabetes. |
| Q85939147 | Vitamin E conditionally inhibits atherosclerosis in ApoE knockout mice by anti-oxidation and regulation of vasculature gene expressions |
Search more.